ANTIMICROBIAL ACTIVITIES OF MEROPENEM AGAINST CLINICALLY ISOLATED STRAINS IN 1997

In order to evaluate antimicrobial activity of meropenem (MEPM), minimum inhibitory concentrations (MICs) of MEPM and control drugs were determined against clinical isolates in 1997. The results were as follows; 1. Antimicrobial activities of MEPM against Gram-positive bacteria were stronger than th...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Japanese journal of antibiotics 1999/12/25, Vol.52(12), pp.695-720
Hauptverfasser: SUZUKI, YUMIKO, MATSUMOTO, YOSHIHIRO, NISHINARI, CHISATO, ENDO, HARUMI, ISHIHARA, RIKA, DEGUCHI, KOICHI
Format: Artikel
Sprache:jpn
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 720
container_issue 12
container_start_page 695
container_title Japanese journal of antibiotics
container_volume 52
creator SUZUKI, YUMIKO
MATSUMOTO, YOSHIHIRO
NISHINARI, CHISATO
ENDO, HARUMI
ISHIHARA, RIKA
DEGUCHI, KOICHI
description In order to evaluate antimicrobial activity of meropenem (MEPM), minimum inhibitory concentrations (MICs) of MEPM and control drugs were determined against clinical isolates in 1997. The results were as follows; 1. Antimicrobial activities of MEPM against Gram-positive bacteria were stronger than those of cephems (CEPs) and were approximately equal to those of imipenem (IPM) and panipenem (PAPM). 2. Carbapenems showed strong antimicrobial activities against Enterobacteriaceae, Glucose non-fermentative Gram-negative rods and Bacteroides fragilis group that were multiple drug resistant including the third generation CEPs. Antimicrobial activities of MEPM against these organisms were stronger than those of IPM and PAPM. By comparing antimicrobial activities of MEPM against Gram-negative bacteria in 1997 with thoseobtained in 1993, increase of resistance was not observed. 3. MIC-ranges of MEPM were low against the resistant strains of Pseudomonas aeruginosa to IPM and PAPM. It was considered that these resistant strains were not expressing oprD products (D2 porin protein), forming main outer membrane porin channels of carbapenems and basic amino acids.
doi_str_mv 10.11553/antibiotics1968b.52.695
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_69444002</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>69444002</sourcerecordid><originalsourceid>FETCH-LOGICAL-j190t-f8ad6646cfd3210da6ca75519a6bb982b99cf37def3716a56131f96dac3ab9f13</originalsourceid><addsrcrecordid>eNpd0E1TgzAQBuCMo2M7tX_ByckbNZuQQI6ItGakoAWd8cQECEqnXwI9-O-l09qDl93DPvseXoQwkAkA5-xeb7o6r7ddXbQghZtPOJ0IyS_QkIIrLG47ziUaEiZcizouDNC4beucMHBc2idcowGQ3hPKh-jVi1I1V_4iflBeiD0_Ve8qVUGC4ymeB4v4JYiCOfZmnoqSFPuhipTvheEHVkkcemnwiJN0cThiFWGQ0rlBV5VetWZ82iP0Ng1S_8kK49nh1VqCJJ1VuboUwhZFVTIKpNSi0A7nILXIc-nSXMqiYk5p-gFCcwEMKilKXTCdywrYCN0dc3fN9ntv2i5b121hViu9Mdt9mwlp2zYhtIe3J7jP16bMdk291s1P9ldCD56PYNl2-tOcgW76ilcm-993xmkG9DD7gLMqvnSTmQ37BVQzdvQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69444002</pqid></control><display><type>article</type><title>ANTIMICROBIAL ACTIVITIES OF MEROPENEM AGAINST CLINICALLY ISOLATED STRAINS IN 1997</title><source>MEDLINE</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>SUZUKI, YUMIKO ; MATSUMOTO, YOSHIHIRO ; NISHINARI, CHISATO ; ENDO, HARUMI ; ISHIHARA, RIKA ; DEGUCHI, KOICHI</creator><creatorcontrib>SUZUKI, YUMIKO ; MATSUMOTO, YOSHIHIRO ; NISHINARI, CHISATO ; ENDO, HARUMI ; ISHIHARA, RIKA ; DEGUCHI, KOICHI</creatorcontrib><description>In order to evaluate antimicrobial activity of meropenem (MEPM), minimum inhibitory concentrations (MICs) of MEPM and control drugs were determined against clinical isolates in 1997. The results were as follows; 1. Antimicrobial activities of MEPM against Gram-positive bacteria were stronger than those of cephems (CEPs) and were approximately equal to those of imipenem (IPM) and panipenem (PAPM). 2. Carbapenems showed strong antimicrobial activities against Enterobacteriaceae, Glucose non-fermentative Gram-negative rods and Bacteroides fragilis group that were multiple drug resistant including the third generation CEPs. Antimicrobial activities of MEPM against these organisms were stronger than those of IPM and PAPM. By comparing antimicrobial activities of MEPM against Gram-negative bacteria in 1997 with thoseobtained in 1993, increase of resistance was not observed. 3. MIC-ranges of MEPM were low against the resistant strains of Pseudomonas aeruginosa to IPM and PAPM. It was considered that these resistant strains were not expressing oprD products (D2 porin protein), forming main outer membrane porin channels of carbapenems and basic amino acids.</description><identifier>ISSN: 0368-2781</identifier><identifier>EISSN: 2186-5477</identifier><identifier>DOI: 10.11553/antibiotics1968b.52.695</identifier><identifier>PMID: 10695025</identifier><language>jpn</language><publisher>Japan: Japan Antibiotics Research Association</publisher><subject>Bacteria - drug effects ; Bacteria - isolation &amp; purification ; Carbapenems - pharmacology ; Cephalosporins - pharmacology ; Drug Resistance, Microbial ; Humans ; Imipenem - pharmacology ; Thienamycins - pharmacology ; Time Factors</subject><ispartof>The Japanese Journal of Antibiotics, 1999/12/25, Vol.52(12), pp.695-720</ispartof><rights>Japan Antibiotics Research Association</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/10695025$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SUZUKI, YUMIKO</creatorcontrib><creatorcontrib>MATSUMOTO, YOSHIHIRO</creatorcontrib><creatorcontrib>NISHINARI, CHISATO</creatorcontrib><creatorcontrib>ENDO, HARUMI</creatorcontrib><creatorcontrib>ISHIHARA, RIKA</creatorcontrib><creatorcontrib>DEGUCHI, KOICHI</creatorcontrib><title>ANTIMICROBIAL ACTIVITIES OF MEROPENEM AGAINST CLINICALLY ISOLATED STRAINS IN 1997</title><title>Japanese journal of antibiotics</title><addtitle>Jpn. J. Antibiotics</addtitle><description>In order to evaluate antimicrobial activity of meropenem (MEPM), minimum inhibitory concentrations (MICs) of MEPM and control drugs were determined against clinical isolates in 1997. The results were as follows; 1. Antimicrobial activities of MEPM against Gram-positive bacteria were stronger than those of cephems (CEPs) and were approximately equal to those of imipenem (IPM) and panipenem (PAPM). 2. Carbapenems showed strong antimicrobial activities against Enterobacteriaceae, Glucose non-fermentative Gram-negative rods and Bacteroides fragilis group that were multiple drug resistant including the third generation CEPs. Antimicrobial activities of MEPM against these organisms were stronger than those of IPM and PAPM. By comparing antimicrobial activities of MEPM against Gram-negative bacteria in 1997 with thoseobtained in 1993, increase of resistance was not observed. 3. MIC-ranges of MEPM were low against the resistant strains of Pseudomonas aeruginosa to IPM and PAPM. It was considered that these resistant strains were not expressing oprD products (D2 porin protein), forming main outer membrane porin channels of carbapenems and basic amino acids.</description><subject>Bacteria - drug effects</subject><subject>Bacteria - isolation &amp; purification</subject><subject>Carbapenems - pharmacology</subject><subject>Cephalosporins - pharmacology</subject><subject>Drug Resistance, Microbial</subject><subject>Humans</subject><subject>Imipenem - pharmacology</subject><subject>Thienamycins - pharmacology</subject><subject>Time Factors</subject><issn>0368-2781</issn><issn>2186-5477</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1999</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpd0E1TgzAQBuCMo2M7tX_ByckbNZuQQI6ItGakoAWd8cQECEqnXwI9-O-l09qDl93DPvseXoQwkAkA5-xeb7o6r7ddXbQghZtPOJ0IyS_QkIIrLG47ziUaEiZcizouDNC4beucMHBc2idcowGQ3hPKh-jVi1I1V_4iflBeiD0_Ve8qVUGC4ymeB4v4JYiCOfZmnoqSFPuhipTvheEHVkkcemnwiJN0cThiFWGQ0rlBV5VetWZ82iP0Ng1S_8kK49nh1VqCJJ1VuboUwhZFVTIKpNSi0A7nILXIc-nSXMqiYk5p-gFCcwEMKilKXTCdywrYCN0dc3fN9ntv2i5b121hViu9Mdt9mwlp2zYhtIe3J7jP16bMdk291s1P9ldCD56PYNl2-tOcgW76ilcm-993xmkG9DD7gLMqvnSTmQ37BVQzdvQ</recordid><startdate>199912</startdate><enddate>199912</enddate><creator>SUZUKI, YUMIKO</creator><creator>MATSUMOTO, YOSHIHIRO</creator><creator>NISHINARI, CHISATO</creator><creator>ENDO, HARUMI</creator><creator>ISHIHARA, RIKA</creator><creator>DEGUCHI, KOICHI</creator><general>Japan Antibiotics Research Association</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>199912</creationdate><title>ANTIMICROBIAL ACTIVITIES OF MEROPENEM AGAINST CLINICALLY ISOLATED STRAINS IN 1997</title><author>SUZUKI, YUMIKO ; MATSUMOTO, YOSHIHIRO ; NISHINARI, CHISATO ; ENDO, HARUMI ; ISHIHARA, RIKA ; DEGUCHI, KOICHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-j190t-f8ad6646cfd3210da6ca75519a6bb982b99cf37def3716a56131f96dac3ab9f13</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>jpn</language><creationdate>1999</creationdate><topic>Bacteria - drug effects</topic><topic>Bacteria - isolation &amp; purification</topic><topic>Carbapenems - pharmacology</topic><topic>Cephalosporins - pharmacology</topic><topic>Drug Resistance, Microbial</topic><topic>Humans</topic><topic>Imipenem - pharmacology</topic><topic>Thienamycins - pharmacology</topic><topic>Time Factors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SUZUKI, YUMIKO</creatorcontrib><creatorcontrib>MATSUMOTO, YOSHIHIRO</creatorcontrib><creatorcontrib>NISHINARI, CHISATO</creatorcontrib><creatorcontrib>ENDO, HARUMI</creatorcontrib><creatorcontrib>ISHIHARA, RIKA</creatorcontrib><creatorcontrib>DEGUCHI, KOICHI</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Japanese journal of antibiotics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SUZUKI, YUMIKO</au><au>MATSUMOTO, YOSHIHIRO</au><au>NISHINARI, CHISATO</au><au>ENDO, HARUMI</au><au>ISHIHARA, RIKA</au><au>DEGUCHI, KOICHI</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>ANTIMICROBIAL ACTIVITIES OF MEROPENEM AGAINST CLINICALLY ISOLATED STRAINS IN 1997</atitle><jtitle>Japanese journal of antibiotics</jtitle><addtitle>Jpn. J. Antibiotics</addtitle><date>1999-12</date><risdate>1999</risdate><volume>52</volume><issue>12</issue><spage>695</spage><epage>720</epage><pages>695-720</pages><issn>0368-2781</issn><eissn>2186-5477</eissn><abstract>In order to evaluate antimicrobial activity of meropenem (MEPM), minimum inhibitory concentrations (MICs) of MEPM and control drugs were determined against clinical isolates in 1997. The results were as follows; 1. Antimicrobial activities of MEPM against Gram-positive bacteria were stronger than those of cephems (CEPs) and were approximately equal to those of imipenem (IPM) and panipenem (PAPM). 2. Carbapenems showed strong antimicrobial activities against Enterobacteriaceae, Glucose non-fermentative Gram-negative rods and Bacteroides fragilis group that were multiple drug resistant including the third generation CEPs. Antimicrobial activities of MEPM against these organisms were stronger than those of IPM and PAPM. By comparing antimicrobial activities of MEPM against Gram-negative bacteria in 1997 with thoseobtained in 1993, increase of resistance was not observed. 3. MIC-ranges of MEPM were low against the resistant strains of Pseudomonas aeruginosa to IPM and PAPM. It was considered that these resistant strains were not expressing oprD products (D2 porin protein), forming main outer membrane porin channels of carbapenems and basic amino acids.</abstract><cop>Japan</cop><pub>Japan Antibiotics Research Association</pub><pmid>10695025</pmid><doi>10.11553/antibiotics1968b.52.695</doi><tpages>26</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0368-2781
ispartof The Japanese Journal of Antibiotics, 1999/12/25, Vol.52(12), pp.695-720
issn 0368-2781
2186-5477
language jpn
recordid cdi_proquest_miscellaneous_69444002
source MEDLINE; EZB-FREE-00999 freely available EZB journals
subjects Bacteria - drug effects
Bacteria - isolation & purification
Carbapenems - pharmacology
Cephalosporins - pharmacology
Drug Resistance, Microbial
Humans
Imipenem - pharmacology
Thienamycins - pharmacology
Time Factors
title ANTIMICROBIAL ACTIVITIES OF MEROPENEM AGAINST CLINICALLY ISOLATED STRAINS IN 1997
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-11T11%3A32%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=ANTIMICROBIAL%20ACTIVITIES%20OF%20MEROPENEM%20AGAINST%20CLINICALLY%20ISOLATED%20STRAINS%20IN%201997&rft.jtitle=Japanese%20journal%20of%20antibiotics&rft.au=SUZUKI,%20YUMIKO&rft.date=1999-12&rft.volume=52&rft.issue=12&rft.spage=695&rft.epage=720&rft.pages=695-720&rft.issn=0368-2781&rft.eissn=2186-5477&rft_id=info:doi/10.11553/antibiotics1968b.52.695&rft_dat=%3Cproquest_pubme%3E69444002%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=69444002&rft_id=info:pmid/10695025&rfr_iscdi=true